National Project Implementation Plan - NVBDCP

More documents

Recommendations

Info

y NIMR for malaria and RMRI for Kala-azar in collaboration with Regional Directorates in the different states. Assistance will be requested from medical colleges and other relevant institutions that have interest and expertise in collaboration with NIMR and RMRI. The proposed activity schedule and time lines for malaria control and Kala-azar will be the same. The description that follows therefore applies to both malaria control and Kala-azar elimination. 7.1.1.4.1 Therapeutic efficacy monitoring Therapeutic efficacy monitoring is integral to the program, and will be carried out by NIMR and other ICMR institutions in collaboration with NVBDCP. A standard protocol for therapeutic efficacy will be used based on WHO recommendations and at least 15 studies will be undertaken every year. The National Institute of Malaria Research Centre (NIMR) will have overall responsibility for implementing this activity which involves finalization of protocols, recruitment and training of staff, assuring the quality, consolidation of the data and organizing annual consultation and feedback. Since the monitoring will be jointly done with the Regional Directors, NIMR will also be responsible for recruitment of Research Officers on contract for the units located with the Regional Directors of ROHFW where no post of Research Officer is in position. The 13 therapeutic teams under NVBDCP located at Regional Offices will work in close co-ordination with the NIMR. An MOU shall be signed with NIMR for effective utilization of manpower that exists in the Regional Offices. Activity schedules Result Indicator Activity Knowledge of the status of resistance level No. of studies conducted and completed Signing of agreement Finalize the study tools and protocol Selection of sites for monitoring Allocation of study to Regional Directors and NIMR field sites Training of researchers Studies commenced Report submission Review of findings jointly with NVBDCP and action taken for program 60 Time schedule July 08 Aug 08 Sep 08 Oct 08 Nov 08 Dec 08 Quarterly starting Mar09 Quarterly starting Mar 09 Responsibility NVBDCP/ NIMR/RMRI NVBDCP/ Agency Agency NVBDCP NVBDCP/ World Bank
7.1.1.4.2 Assess drug quality This section will comprise of systematic drug quality assurance system which will be an inbuilt component of NVBDCP. Activity schedules Result Indicator Activity Drug quality assessed No of studies conducted Finalize the study tool and protocol Signing of agreement Selection of staff and training Studies commenced Report submission Joint review of progress Action taken by program Time schedule Sept 08 Oct 08 Nov 08 Dec 08 Quarterly start Mar 09 Quarterly starting Mar 09 Jun 09 Responsibility NVBDCP/ NIMR/RM RI NVBDCP NVBDCP/ AGENCY AGENCY NVBDCP/ state NVBDCP/ World Bank NVBDCP NVBDCP will request Consultant support from WHO. He/she will work closely with NIMR for development of protocol. The protocol shall be discussed by experts, WHO and World Bank. 7.1.1.4.3 Vector Susceptibility Studies The efforts will comprise of studies on vector resistance for the insecticides use in the programme for changing of insecticides on the basis of susceptibility test results. This study will be coordinated and conducted by Zonal Entomological teams in the states, NIMR, RMRI and Universities (Zoology department). Every year at least 40-50 studies in designated sites will be completed by NIMR entomological team in collaboration with state and Regional offices. This study will help to evolve a comprehensive insecticide map for India and this will help better informed insecticide policy. 61
Page 1 and 2:
Project Credit No.: 4461-IN Project
Page 3 and 4:
TABLE OF CONTENTS Abbreviations and
Page 5 and 6:
CHAPTERS Page. No. 13. Governance a
Page 7 and 8:
Abbreviations and Acronyms ABER ACD
Page 9 and 10:
Chapter 1 Situational analysis Intr
Page 11 and 12:
The following matrix summarizes the
Page 13 and 14:
The Enhanced Malaria Control Projec
Page 15 and 16:
Inadequate attention to mosquitogen
Page 17 and 18: Current Malaria Treatment Policy in
Page 19 and 20: chloroquine in P. falciparum cases
Page 21 and 22: the in depth review in 2006, the co
Page 23 and 24: incentives to assist kala-azar pati
Page 25 and 26: provision of general health service
Page 27 and 28: f. The project will introduce a sen
Page 29 and 30: Where microscopy result is not avai
Page 31 and 32: e. Supporting interventions for Kal
Page 33 and 34: The following table summarizes the
Page 35 and 36: e available within 24 hours. In oth
Page 37 and 38: 4. Behavior Change Communication A
Page 39 and 40: and also support the implementation
Page 41 and 42: Chapter 5 Malaria Control 5.1 Proje
Page 43 and 44: Result Indicator Activity Severe ca
Page 45 and 46: contact key informants in the villa
Page 47 and 48: coverage and its quality. Other tha
Page 49 and 50: 5.2 Other Issues 5.2.1 Therapeutic
Page 51 and 52: Chapter 6 Elimination of Kala-azar
Page 53 and 54: Table - 1 Activity schedule for the
Page 55 and 56: partner with the private and NGO se
Page 57 and 58: strategy will help economize insect
Page 59 and 60: esearch proposed for kala-azar will
Page 61 and 62: implementation of good pesticide ma
Page 63 and 64: Activity (include s malaria and kal
Page 65 and 66: Activity Sub Activity Tools Interna
Page 67: Environmental studies and impact of
Page 71 and 72: 1. as staff responsible for providi
Page 73 and 74: S. No. Supportive Staff Designation
Page 75 and 76: The key malaria control and kala-az
Page 77 and 78: Project Districts for malaria contr
Page 79 and 80: and appraisal. Additional technical
Page 81 and 82: Sl. No. 1 2 3 4 5 6 7 8 9 10 11 Act
Page 83 and 84: Sl. No. 23 24 25 26 27 28 29 Activi
Page 85 and 86: Cost Summary of Training Training C
Page 87 and 88: area, and a strengthened supply cha
Page 89 and 90: Chapter 9 MONITORING AND EVALUATION
Page 91 and 92: year, covering all endemic district
Page 93 and 94: treat malaria correctly. Modules fo
Page 95 and 96: insecticides in use in 200 sites, w
Page 97 and 98: Purpose Level Person Frequency Comm
Page 99 and 100: Monitoring and Evaluation will incl
Page 101 and 102: finger-prick blood sample taken by
Page 103 and 104: A Total mid-year population B Total
Page 105 and 106: 2a. Elimination of kala-azar a.i. P
Page 107 and 108: Arrangements for Outcome and Result
Page 109 and 110: Component Three: Policy and Strateg
Page 111 and 112: Project Steering Committee: A steer
Page 113 and 114: service delivery in public and priv
Page 115 and 116: 2 Additional Staff in District VBD
Page 117 and 118: The quality of Diagnostic Kits on t
Page 119 and 120:
Percentage of individuals in projec
Page 121 and 122:
11.2 Financial Management at the Ce
Page 123 and 124:
separate financial management cell
Page 125 and 126:
World Bank will review of the annua
Page 127 and 128:
In parallel and in support of enhan
Page 129 and 130:
Risk Residual Risk Rating Risk Miti
Page 131 and 132:
Chapter 12 Procurement Arrangements
Page 133 and 134:
agencies for taking up inspections
Page 135 and 136:
contractor/supplier. However, the v
Page 137 and 138:
12.3.4 Procurement Methods The tabl
Page 139 and 140:
(commercial or UN agency acting as
Page 141 and 142:
procurement agent) which are not pr
Page 143 and 144:
B) Consultancy Services (>US$200,00
Page 145 and 146:
4. Contract Awards for Consultancie
Page 147 and 148:
monitoring of procurement undertake
Page 149 and 150:
Topic Type of risk Mitigating Actio
Page 151 and 152:
Page 153 and 154:
use, fraud, corruption may still re
Page 155 and 156:
Page 157 and 158:
Chapter 14 Economic and Financial A
Page 159 and 160:
diagnosis and treatment, causing su
Page 161 and 162:
Table 1: Estimated Costs of Current
Page 163 and 164:
Table 3: Estimated Incremental Cost
Page 165 and 166:
Chapter 15 Safeguard Policy Issues
Page 167 and 168:
State/Uni on Territory Number of Pr
Page 169 and 170:
15.3.1 Surveillance, Case Diagnosis
Page 171 and 172:
eluctant to allow their homes to be
Page 173 and 174:
equipment, optimal coverage and qua
Page 175 and 176:
Social Devpt. and BCC Consultants a
Page 177 and 178:
Action to be Taken supportive drugs
Page 179 and 180:
Action to be Taken Distributing LLI
Page 181 and 182:
Action to be Taken At what Level 17
Page 183 and 184:
National Level: As the Borrower is
Page 185 and 186:
vulnerable groups. estimates. Table
Page 187 and 188:
Routine Program Monitoring: At the
Page 189 and 190:
15.11.4 Application activities: Saf
Page 191 and 192:
For effective implementation of the
Page 193 and 194:
Action Responsibility By When Cost
Page 195 and 196:
procured under the project; (6) bi-
Page 197 and 198:
of each identified district to succ
Page 199 and 200:
Annexure 1 MALARIA CASES & DEATHS S
Page 201 and 202:
Annexure 2 KALA-AZAR CASES & DEATHS
show all

National Project Implementation Plan - NVBDCP

Create successful ePaper yourself

Delete template?

Save as template?